Physicians Struggle With Antiquated Reimbursement for Next-Generation Testing
May 22nd 2015
The growing use of genetic biomarker tests to screen, monitor, diagnose, and treat patients with cancer has the potential to improve outcomes and reduce costs, but payment systems for covering and reimbursing for these tests have fallen behind the times.